A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial

BACKGROUND: Genitourinary (GU) or gastrointestinal (GI) complications and tumor relapse can occur in the long term after radiotherapy for prostate cancer. OBJECTIVE: To assess the late tolerance and relapse-free survival (RFS) in patients undergoing hypofractionated stereotactic boost therapy after...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquier, David, Nickers, Philippe, Peiffert, Didier, Maingon, Philippe, Pommier, Pascal, Lacornerie, Thomas, Tresch, Emmanuelle, Barthoulot, Maël, Lartigau, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403693/
https://www.ncbi.nlm.nih.gov/pubmed/37545850
http://dx.doi.org/10.1016/j.euros.2023.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403693/
https://www.ncbi.nlm.nih.gov/pubmed/37545850
http://dx.doi.org/10.1016/j.euros.2023.06.003

Ejemplares similares